Nonacog alfa
BeneFIX (nonacog alfa) is a protein pharmaceutical. Nonacog alfa was first approved as BeneFIX on 1997-08-27. It is used to treat factor VII deficiency, hemophilia a, hemophilia b, and hypoprothrombinemias in the USA. It has been approved in Europe to treat hemophilia b.
| Trade Name | BeneFIX |
|---|---|
| Common Name | Nonacog alfa |
| Indication | factor vii deficiency, hemophilia a, hemophilia b, hypoprothrombinemias |
| Drug Class |
